Sickle Cell Header

Dashed Line

Agenda | Speakers

Dashed Line

 

 

Speakers

   

Session Chairs

 
Kenneth I. Ataga, MD
Françoise Bernaudin, MD
Hunter C. Champion, MD, PhD
Bruce Freeman, PhD
Paul S. Frenette MD
Mark T. Gladwin, MD
Robert P. Hebbel, MD
Cheryl A. Hillery, MD
Henrietta D. Hyatt-Knorr, MA
David A. Kass, MD
Gregory J. Kato, MD
Dhananjay K. Kaul, PhD
Anh Le, PhD
Daniel Levy, MD
Claudia R. Morris, MD
Kirkwood A. Pritchard, Jr., PhD
Martin H. Steinberg, MD
Marilyn J. Telen, MD
Tim M. Townes, PhD
Mary E. Fabry, PhD
Robert P. Hebbel, MD
Lewis L. Hsu, MD, PhD
Jeffery L. Miller, M.D.
Constance Tom Noguchi, PhD
Marie J. Stuart, MD
James G. Taylor VI, MD
John Fitzgerald Tisdale, MD
Gregory M. Vercellotti, MD
 

Dashed Line

 
Ataga

Kenneth I. Ataga, MD

Assistant Professor of Medicine
Division of Hematology/Oncology
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina

Presentation Title: Hemostatic Activation in Sickle Cell Disease
August 28, 2008 8:00 AM - 8:30 AM

 

Bernaudin




Françoise Bernaudin, MD

Pediatrie
Reference Center for Sickle Cell Disease, Pediatrics,
Centre Hospitalier Intercommunal Créteil
Créteil, France

Presentation Title: Hemolytic Rate and Risk of Stroke in Children with Sickle Cell Disease
August 28, 2008 8:30AM-9:00AM

 

 

Champion


Hunter C. Champion, MD, PhD

Assistant Professor of Medicine
Johns Hopkins University
Baltimore, Maryland

Presentation Title: Low Nitric Oxide Bioactivity and Priapism
August 28, 2008 9:00AM-9:30AM

Champion


Mary E. Fabry, PhD

Professor of Medicine
Albert Einstein College of Medicine
Bronx Comprehensive Sickle Cell Center
Bronx, New York

Session Chair: Hemostatic Activation and Genomics of Vasculopathy
August 28, 2008 8:00AM - 10:30AM



Freeman

Bruce Freeman, PhD

Irwin Fridovich Professor
Chair of Pharmocology
University of Pittsburgh School of Medicine
Pittsburgh, Pennsylvania

Presentation Title: Catalytic Nitric Oxide Scavenging by Oxidases
and Oxygenases
August 27, 2008 2:10PM - 2:40PM

Frenette


Paul S. Frenette, MD

Professor of Medicine
Mount Sinai School of Medicine
New York, New York

Presentation Title: Mediators of Cell Adhesion in Sickle Cell Disease
August 27, 2008 3:30PM-4:00PM

 

Gladwin


Mark T. Gladwin, MD

Chief, Pulmonary and Vascular Medicine Branch
National Heart, Lung, and Blood Institute
NIH, DHHS
Bethesda, Maryland

Presentation Title: Nitric Oxide Scavenging by Cell-Free
Plasma Hemoglobin
August 27, 2008 1:40PM-2:10PM

 

Hebbel







Robert P. Hebbel, MD

Regents Professor
George Clark Professor
Director, Vascular Biology Center Medical School
University of Minnesota
Minneapolis, Minnesota

Session Chair: Vascular Dysfunction and Cell Adhesion
August 27, 2008 3:00PM - 5:00PM

Presentation Title: Oxidation, Hemostatic Activation and Adhesion
August 27, 2008 1:10PM - 1:40PM

 

Hillery


Cheryl A. Hillery, MD

Assistant Professor of Pediatrics , Hematology/Oncology
Medical College of Wisconsin
Milwaukee, Wisconsin

Presentation Title: Endothelial Dysfunction in the Sickle Cell Mouse
August 27, 2008 4:00PM - 4:30PM

 

Hsu


Lewis L. Hsu, MD, PhD

Associate Professor of Pediatrics
St. Christopher’s Hospital for Children
Philadelphia, Pennsylvania

Session Chair: Translational Therapeutics
August 28, 2008 10:50AM - 11:50AM

 

Knorr 

 


Henrietta D. Hyatt-Knorr, MA

Director, Policy and Program Planning and Analysis
Office of Rare Diseases
Office of the Director
NIH, DHHS
Bethesda, Maryland

Presentation Title: Welcome Remarks
August 27, 2008 1:05PM - 1:10PM

 

Kass 

 


David A. Kass, MD

Abraham and Virginia Weiss Professor of Cardiology
Professor of Medicine
Professor of Biomedical Engineering
Johns Hopkins Medical Institutions
Baltimore, Maryland

Presentation Title: NOS Uncoupling in Vascular Disease
August 28, 2008 2:50PM – 3:20PM

 

Kato


Gregory J. Kato, MD

Senior Staff Physician, Critical Care Medicine Department
Director, Sickle Cell Vascular Disease Unit
National Heart, Lung, and Blood Institute
NIH, DHHS
Bethesda, Maryland

Session Chair: Atherosclerosis: Parallels with Sickle Vasculopathy?
August 28, 2008 1:20PM - 3:40PM

Presentation Title: Vascular Targets for Small Molecule Therapeutics
August 28, 2008 10:50AM - 11:20AM

 

Kaul


Dhananjay K. Kaul, PhD


Professor of Medicine
Albert Einstein College of Medicine
Bronx, New York

Presentation Title: Nitric Oxide Resistance in the Sickle Cell Mouse
August 27, 2008 3:00PM - 3:30PM

 

Le


Anh Le, PhD

Associate Professor of Medicine
Director, Emory Lipid Research Laboratory
Emory University and Atlanta VA Medical Center
Atlanta, Georgia

Presentation Title: The Role of Hypertriglyceridemia in Atherosclerosis
August 28, 2008 1:20PM-1:50PM

 

Levy


Daniel Levy, MD

Professor of Medicine
Boston University School of Medicine
Framingham, Massachusetts

Presentation Title: Systolic Hypertension in Vasculopathy:
Lessons from the Framingham Heart Study
August 28, 2008 2:20PM - 2:50PM

 

Morris


Jeffery Lynn Miller, MD

National Institute of Diabetes and Digestive and Kidney Diseases
NIH, DHHS
Bethesda, Maryland

Session Chair: Disrupted Nitric Oxide Metabolism and Oxidative Stress
August 27, 2008 1:10 PM - 2:40 PM

 

Morris


Claudia R. Morris, MD

Director of Fellowship Research
Children’s Hospital Oakland Research Institute
Oakland, California

Presentation Title: Glutathione Dysregulation in Sickle Cell Disease
August 27, 2008 4:30PM - 5:00PM

 

Morris


Constance Tom Noguchi, PhD

National Institute of Diabetes and Digestive and Kidney Diseases
NIH, DHHS
Bethesda, Maryland

Session Chair: Disrupted Nitric Oxide Metabolism and Oxidative Stress
August 27, 2008 1:10 PM - 2:40 PM

 

Pritchard


Kirkwood A. Pritchard, Jr., PhD

Professor
Vice-chair of Research for Surgery
Director of Translational Vascular Biology Program
Children’s Research Institute
Milwaukee, Wisconsin

Presentation Title: Apolipoproteins in Sickle Cell Vasculopathy
August 28, 2008 1:50PM - 2:20PM

 

Steinberg


Martin H. Steinberg, MD

Professor of Medicine, Pediatrics, Pathology and Laboratory Medicine
Boston University School of Medicine
Boston, Massachusetts

Presentation Title: Genomic Markers of Sickle Cell Priapism
and Leg Ulcers
August 28, 2008 9:30AM - 10:00AM

 

Stuart



Marie J. Stuart, MD

Professor
Department of Pediatrics, Division of Hematology,
The Marian Anderson Sickle Cell Anemia Research Hematology Laboratories
Thomas Jefferson University
Philadelphia, Pennsylvania

Session Chair: Vascular Dysfunction and Cell Adhesion
August 27, 2008 3:00PM - 5:00PM

 

Taylor



James G. Taylor VI, MD

Staff Clinician
Pulmonary and Vascular Medicine Branch
National Heart, Lung, and Blood Institute
NIH, DHHS
Bethesda, Maryland

Session Chair: Hemostatic Activation and Genomics of Vasculopathy
August 28, 2008 8:00AM - 10:30AM

 

Telen


Marilyn J. Telen, MD

Chief, Division of Hematology
Director, Duke-UNC Comprehensive Sickle Cell Center
Duke University
Durham, North Carolina

Presentation Title: Genomic Markers of Sickle Cell Pulmonary Hypertension
August 28, 2008 10:00AM - 10:30AM

 

Tisdale



John Fitzgerald Tisdale, MD

Senior Investigator
Molecular and Clinical Hematology Branch
National Institute of Diabetes and Digestive and Kidney
Diseases
NIH, DHHS
Bethesda, Maryland

Session Chair: Translational Therapeutics
August 28, 2008 10:50AM - 11:50AM

 

Townes


Tim M. Townes, PhD

Professor/Chairman, Biochemistry and Molecular Genetics
University of Alabama at Birmingham
Birmingham, Alabama

Presentation Title: Cellular Approaches for Gene Therapy for
Sickle Cell Disease
August 28, 2008 11:20AM - 11:50AM

 

Vercellotti



Gregory M. Vercellotti, MD

Professor of Medicine
Division of Hematology, Oncology, Transplantation
University of Minnesota Medical School
Minneapolis, Minnesota

Session Chair: Atherosclerosis: Parallels with Sickle Vasculopathy?
August 28, 2008 1:20PM - 3:40PM